Healthcare & Life Sciences
Spyre Therapeutics
United Statesspyre.com
Spyre Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Spyre Therapeutics
Based in the United States, Spyre Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Spyre Therapeutics is a clinical-stage biotechnology company developing novel antibody therapies targeting validated mechanisms related to immune-mediated gastrointestinal and rheumatic diseases, including inflammatory bowel disease.
Explore Spyre Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.